Previous Close | 260.12 |
1-Year Change | 48.84% |
6-Months Change | 38.9% |
3-Months Change | 32.77% |
Moving Avg (50d) | 237.77 |
Moving Avg (200d) | 198.05 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 18.2B |
Beta (3-Years) | 1.23 |
Revenue Growth (ttm) | 25.23% |
Net Profit Margin (ttm) | 7.71% |
Return On Assets (ttm) | 4.86% |
EPS (ttm) | 1.72 |
PE Ratio (ttm) | 151.23 |
Dividend Yield | % |
Asset Description: | Insulet Corporation |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
271.912 | 279.909 | 285.241 | 293.238 | 306.567 | 319.896 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |